83 results
8-K
BGLC
BioNexus Gene Lab Corp
9 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:37pm
5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other
DEF 14C
f9po j68v08pfg8g
29 Feb 24
Information statement
5:16pm
PRE 14C
qq3kn7obon670
26 Jan 24
Preliminary information
4:05pm
8-K
jzhl3sch0fl76eqb
13 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:40pm
8-K
EX-1.1
3wlwrp6sdd
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
424B4
tv0 m9bsqwso78wvx
21 Jul 23
Prospectus supplement with pricing info
3:37pm